PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, VA, USA.\', \'Department of Medicine, Boston University School of Medicine, Boston, MA, USA.\', \'Department of Medicine, Weill Cornell Medicine, New York, NY, USA.\', \'Department of Ophthalmology, Tufts University School of Medicine, Boston, MA 02111, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/1753466620951053
?:hasPublicationType
?:journal
  • Therapeutic advances in respiratory disease
is ?:pmid of
?:pmid
?:pmid
  • 32873175
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.081
?:rankingScore_hIndex
  • 29
is ?:relation_isRelatedTo_publication of
?:title
  • Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease.
?:type

Metadata

Anon_0  
expand all